Marisol Huerta

2.0k total citations
42 papers, 1.2k citations indexed

About

Marisol Huerta is a scholar working on Oncology, Pathology and Forensic Medicine and Cancer Research. According to data from OpenAlex, Marisol Huerta has authored 42 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 15 papers in Pathology and Forensic Medicine and 15 papers in Cancer Research. Recurrent topics in Marisol Huerta's work include Genetic factors in colorectal cancer (15 papers), Colorectal Cancer Treatments and Studies (15 papers) and Cancer Genomics and Diagnostics (14 papers). Marisol Huerta is often cited by papers focused on Genetic factors in colorectal cancer (15 papers), Colorectal Cancer Treatments and Studies (15 papers) and Cancer Genomics and Diagnostics (14 papers). Marisol Huerta collaborates with scholars based in Spain, United States and Italy. Marisol Huerta's co-authors include Susana Roselló, Andrés Cervantes, Valentina Gambardella, Noelia Tarazona, Tania Fleitas, Carolina Martínez‐Ciarpaglini, Francisco Gimeno-Valiente, Josefa Castillo, Desamparados Roda and Juan Miguel Cejalvo and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Biochemical Journal.

In The Last Decade

Marisol Huerta

38 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marisol Huerta Spain 18 610 491 398 368 253 42 1.2k
Noelia Tarazona Spain 19 584 1.0× 433 0.9× 383 1.0× 490 1.3× 190 0.8× 58 1.3k
Maria Pia Morelli United States 19 863 1.4× 350 0.7× 355 0.9× 449 1.2× 272 1.1× 70 1.3k
Valentina Gambardella Spain 18 755 1.2× 485 1.0× 471 1.2× 474 1.3× 236 0.9× 85 1.5k
Giorgia Migliardi Italy 18 719 1.2× 277 0.6× 352 0.9× 515 1.4× 180 0.7× 28 1.3k
Hao‐Xiang Wu China 22 596 1.0× 393 0.8× 289 0.7× 520 1.4× 162 0.6× 38 1.3k
Yoshiya Horimoto Japan 20 694 1.1× 378 0.8× 235 0.6× 495 1.3× 154 0.6× 97 1.2k
Mariam Jamal‐Hanjani United Kingdom 18 488 0.8× 424 0.9× 386 1.0× 447 1.2× 107 0.4× 42 1.1k
Jiayi Wu China 20 853 1.4× 656 1.3× 223 0.6× 281 0.8× 233 0.9× 87 1.3k
Ashiq Masood United States 17 574 0.9× 308 0.6× 366 0.9× 485 1.3× 178 0.7× 54 1.2k
Ramon Andrade de Mello Portugal 21 745 1.2× 314 0.6× 565 1.4× 477 1.3× 108 0.4× 89 1.4k

Countries citing papers authored by Marisol Huerta

Since Specialization
Citations

This map shows the geographic impact of Marisol Huerta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marisol Huerta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marisol Huerta more than expected).

Fields of papers citing papers by Marisol Huerta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marisol Huerta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marisol Huerta. The network helps show where Marisol Huerta may publish in the future.

Co-authorship network of co-authors of Marisol Huerta

This figure shows the co-authorship network connecting the top 25 collaborators of Marisol Huerta. A scholar is included among the top collaborators of Marisol Huerta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marisol Huerta. Marisol Huerta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roselló, Susana, Noelia Tarazona, Marisol Huerta, et al.. (2025). Advances in the management of locally advanced rectal cancer: A shift toward a patient-centred approach to balance outcomes and quality of life. Cancer Treatment Reviews. 140. 103015–103015.
2.
Lucas, B. Daniel, Begoña Heras, Noelia Tarazona, et al.. (2025). Extended tumor area-based stratification score combining tumor budding and stroma identifies a high-risk, immune-depleted group in localized microsatellite-stable colon cancer patients. Pathology - Research and Practice. 269. 155871–155871.
3.
Papaccio, Federica, Manuel Cabeza-Segura, Francisco Gimeno-Valiente, et al.. (2025). Decoding chromosomal instability insights in CRC by integrating omics and patient-derived organoids. Journal of Experimental & Clinical Cancer Research. 44(1). 77–77. 4 indexed citations
4.
Gimeno-Valiente, Francisco, Carolina Martínez‐Ciarpaglini, Valentina Gambardella, et al.. (2024). 583P COMPReS study: Multiomic profiling reveals organ-specific differences in metastases and identifies novel predictive biomarkers in relapsed localized colon cancer. Annals of Oncology. 35. S472–S472. 1 indexed citations
5.
Carbonell‐Asins, Juan Antonio, Valentina Gambardella, Marisol Huerta, et al.. (2024). Minimal residual disease in colorectal cancer. Tumor-informed versus tumor-agnostic approaches: unraveling the optimal strategy. Annals of Oncology. 36(3). 263–276. 20 indexed citations
6.
Papaccio, Federica, Francisco Gimeno-Valiente, Manuel Cabeza-Segura, et al.. (2023). “Proteotranscriptomic analysis of advanced colorectal cancer patient derived organoids for drug sensitivity prediction”. Journal of Experimental & Clinical Cancer Research. 42(1). 8–8. 49 indexed citations
7.
Gimeno-Valiente, Francisco, Valentina Gambardella, Carolina Martínez‐Ciarpaglini, et al.. (2023). Sequencing paired tumor DNA and white blood cells improves circulating tumor DNA tracking and detects pathogenic germline variants in localized colon cancer. ESMO Open. 8(6). 102051–102051. 6 indexed citations
8.
Bravo, Miren, Federica Papaccio, Carolina Martínez‐Ciarpaglini, et al.. (2020). 488P Patient-derived organoids as a tool for modelling localized colorectal cancer. Annals of Oncology. 31. S448–S448. 2 indexed citations
9.
Gambardella, Valentina, Josefa Castillo, Noelia Tarazona, et al.. (2020). The role of tumor-associated macrophages in gastric cancer development and their potential as a therapeutic target. Cancer Treatment Reviews. 86. 102015–102015. 232 indexed citations
10.
Gimeno-Valiente, Francisco, Ángela L. Riffo‐Campos, Guillermo Ayala, et al.. (2020). EPDR1 up-regulation in human colorectal cancer is related to staging and favours cell proliferation and invasiveness. Scientific Reports. 10(1). 3723–3723. 17 indexed citations
11.
Henriksen, Tenna Vesterman, N. Tarazona, Thomas Reinert, et al.. (2020). 420P Minimal residual disease detection and tracking tumour evolution using ctDNA in stage I-III colorectal cancer patients. Annals of Oncology. 31. S419–S420. 2 indexed citations
12.
Gambardella, Valentina, Tania Fleitas, Noelia Tarazona, et al.. (2019). Towards precision oncology for HER2 blockade in gastroesophageal adenocarcinoma. Annals of Oncology. 30(8). 1254–1264. 20 indexed citations
13.
Tarazona, N., Francisco Gimeno-Valiente, Valentina Gambardella, et al.. (2019). Targeted next-generation sequencing of circulating-tumor DNA for tracking minimal residual disease in localized colon cancer. Annals of Oncology. 30(11). 1804–1812. 190 indexed citations
14.
Falco, Vincenzo De, Stefania Napolitano, Susana Roselló, et al.. (2019). How we treat metastatic colorectal cancer. ESMO Open. 4(Suppl 2). e000813–e000813. 60 indexed citations
15.
Martínez‐Ciarpaglini, Carolina, Tania Fleitas, Valentina Gambardella, et al.. (2019). Assessing molecular subtypes of gastric cancer: microsatellite unstable and Epstein-Barr virus subtypes. Methods for detection and clinical and pathological implications. ESMO Open. 4(3). e000470–e000470. 40 indexed citations
16.
Martínez‐Ciarpaglini, Carolina, Sara S. Oltra, Susana Roselló, et al.. (2018). Low miR200c expression in tumor budding of invasive front predicts worse survival in patients with localized colon cancer and is related to PD-L1 overexpression. Modern Pathology. 32(2). 306–313. 33 indexed citations
17.
Sabater, Luís, Elena Muñoz‐Forner, Susana Roselló, et al.. (2018). Borderline resectable pancreatic cancer. Challenges and controversies. Cancer Treatment Reviews. 68. 124–135. 29 indexed citations
18.
Gambardella, Valentina, Josefa Castillo, Francisco Gimeno-Valiente, et al.. (2017). Gene expression changes responsible for lapatinib acquired resistance in HER2 positive gastric cancer cell lines: a microarray analysis. Annals of Oncology. 28. vii16–vii16. 1 indexed citations
19.
Martín-Martorell, Paloma, Marisol Huerta, Rosario Abellán, et al.. (2017). Coexistence of EGFR, KRAS, BRAF, and PIK3CA Mutations and ALK Rearrangement in a Comprehensive Cohort of 326 Consecutive Spanish Nonsquamous NSCLC Patients. Clinical Lung Cancer. 18(6). e395–e402. 31 indexed citations
20.
Martín-Martorell, Paloma, B. Bermejo De Las Heras, José Alejandro Pérez Fidalgo, et al.. (2014). Subcutaneous trastuzumab: drug development and current position. Clinical & Translational Oncology. 16(10). 859–864. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026